Form 4: Ascendis Pharma A/S Director Receives Stock Grant
Insider Transaction (Form 4)
Jean Jacques Bienaime, a Director of Ascendis Pharma A/S, reported multiple transactions in common stock on April 14, 2026.
Summary
- Disposition to the issuer: disposed of 9,160 Warrants on April 14, 2026 (Direct).
- Grant/award: acquired 9,160 Warrants on April 14, 2026; holds 9,160 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jean Jacques Bienaime — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-04-14 | Disposition to the issuer | Warrants | 9,160 | — | — | 0 |
| 2026-04-14 | Grant/award | Warrants | 9,160 | — | — | 9,160 |
Key Dates
| Date | Description |
|---|---|
| 2026-04-14 | Disposition to the issuer (9,160 shares) |
| 2026-04-14 | Grant/award (9,160 shares) |
Keywords
insider transaction, Form 4, ASND, Ascendis Pharma A/S, neutral, Jean Jacques Bienaime
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.